Psyence Biomedical Ltd (PBM)

Dec 31, 2024

Psyence Biomedical Issues Pre-Funded Share Purchase Warrant - TipRanks

Dec 31, 2024

Dec 27, 2024

Psyence Biomed Announces Closing of $2.0 Million Private Placement - GlobeNewswire

Dec 27, 2024

Dec 27, 2024

Psyence Biomed (PBM) Raises $2M in Private Placement with Warrant Coverage, Led by H.C. Wainwright - StockTitan

Dec 27, 2024

Dec 24, 2024

Psyence Biomedical Regains Nasdaq Compliance, Fortifying Market Position - Yahoo Finance

Dec 24, 2024

Dec 24, 2024

Psyence Biomed announces $2 million private placement By Investing.com - Investing.com Nigeria

Dec 24, 2024

Dec 23, 2024

PBMPsyence Biomedical Ltd. Common Shares Latest Stock News & Market Updates - StockTitan

Dec 23, 2024

Dec 23, 2024

Psyence Unveils Private Placement - Baystreet.ca

Dec 23, 2024

Dec 23, 2024

Psyence Biomed announces $2 million private placement - Investing.com

Dec 23, 2024

Dec 23, 2024

Psyence Biomed Announces $2.0 Million Private Placement - The Manila Times

Dec 23, 2024

Dec 23, 2024

Psyence Biomed Secures $2M Private Placement with Strategic Warrant Offering - StockTitan

Dec 23, 2024

Dec 23, 2024

Psyence Biomedical Achieves Full Nasdaq Compliance, Advances Clinical Trial Plans with $5.6M War Chest - StockTitan

Dec 23, 2024

Dec 20, 2024

US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' - Benzinga

Dec 20, 2024

Dec 19, 2024

Psyence Biomedical Signs Exclusive Licensing Agreement with Optimi Health - TipRanks

Dec 19, 2024

Dec 18, 2024

Psyence Biomedical Advances in Phase IIb Psilocybin Clinical Trial - TipRanks

Dec 18, 2024

Dec 17, 2024

Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial - The Manila Times

Dec 17, 2024

Dec 17, 2024

Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial - Newsfile

Dec 17, 2024

Dec 11, 2024

Psyence Biomedical executes binding agreements with Optimi Health - Yahoo Finance

Dec 11, 2024

Dec 10, 2024

Psyence Biomedical stock soars on binding agreements with Optimi Health - MSN

Dec 10, 2024

Dec 10, 2024

Psyence Biomed Executes Binding Agreements with Optimi Health Corp - Marketscreener.com

Dec 10, 2024

Dec 10, 2024

Psyence Biomed Executes Binding Agreements with Optimi Health Corp. - The Manila Times

Dec 10, 2024

Dec 10, 2024

Psyence Biomed Secures Landmark Global Psilocybin Supply Deal for Palliative Care Drug Development - StockTitan

Dec 10, 2024

Dec 07, 2024

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times

Dec 07, 2024

Dec 06, 2024

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle - EIN News

Dec 06, 2024

Dec 04, 2024

Psyence Biomedical Boosts Equity to Meet Nasdaq Rules - TipRanks

Dec 04, 2024

Dec 04, 2024

Psyence Biomedical Revises Debt-for-Equity Deal - TipRanks

Dec 04, 2024

Dec 03, 2024

Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress By Investing.com - Investing.com Canada

Dec 03, 2024

Dec 03, 2024

Psyence Biomed Strengthens Position with Valuable Stake and Trials - TipRanks

Dec 03, 2024

Dec 03, 2024

Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress - The Manila Times

Dec 03, 2024

Dec 03, 2024

Psyence Biomedical issues letter to shareholders - TipRanks

Dec 03, 2024

Nov 25, 2024

Psyence Biomedical Ltd trading halted, news pending - TipRanks

Nov 25, 2024

Nov 21, 2024

Psyence Biomed granted Nasdaq listing extension By Investing.com - Investing.com Australia

Nov 21, 2024

Nov 20, 2024

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga

Nov 20, 2024

Nov 20, 2024

Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report

Nov 20, 2024

Nov 20, 2024

Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN

Nov 20, 2024

Nov 20, 2024

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times

Nov 20, 2024

Nov 20, 2024

Psyence Biomed granted Nasdaq listing extension - Investing.com

Nov 20, 2024

Nov 20, 2024

Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM

Nov 20, 2024

Nov 20, 2024

Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN

Nov 20, 2024

Nov 19, 2024

Psyence Biomed announces share consolidation date - Investing.com India

Nov 19, 2024

Nov 19, 2024

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation - The Manila Times

Nov 19, 2024

Nov 19, 2024

Psyence Biomedical Implements 1-for-75 Share Consolidation to Meet Nasdaq Requirements | PBM Stock News - StockTitan

Nov 19, 2024

Nov 13, 2024

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq - The Manila Times

Nov 13, 2024

Nov 12, 2024

Psyence Biomedical Shareholders Approve 75:1 Stock Split Amid Nasdaq Compliance Challenge | PBM Stock News - StockTitan

Nov 12, 2024